Skip to Main Content

Paper Details

Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.
Clin Gastroenterol Hepatol
18
2021
CD, Crohn's Disease, Crohn's disease, IBD-, IBD-U, Tofacitinib, inflammatory bowel disease, patients, tofacitinib
Author NameAffiliation
George P ChristophiWashington University in Saint Louis School of Medicine, Missouri Steward Center for Inflammatory Bowel Diseases, Florida University of Central Florida College of Medicine
Robert HirtenIcahn School of Medicine at Mount Sinai
Christina HaCedars Sinai Medical Center
Benjamin L CohenIcahn School of Medicine at Mount Sinai, Digestive Disease and Surgery Institute, Cleveland Clinic
Gaurav SyalCedars Sinai Medical Center
Jean-Frederic ColombelIcahn School of Medicine at Mount Sinai
  • 1 - 6

Datasets